Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State as the First Presentation of Acromegaly: Case Report and Literature Review

Abstract

Acromegaly is characterized by excessive growth hormone secretion and is usually associated with glucose intolerance or diabetes mellitus. It is rare to be associated with life-threatening diabetes emergencies. Here, we present a case of a 38-year-old woman who initially presented with a severe hyperglycemia crisis that meets the criteria for both diabetes ketoacidosis and hyperosmolar hyperglycemic state. Subsequently, she was found to exhibit signs of typical acromegaly, including enlargement of hands, thick skin, and interdental spacing. The diagnosis was established based on typical clinical manifestations, hormonal assays, and radiological findings confirming pituitary macroadenoma. Timely identification and diagnosis are crucial for mitigating the potential complications associated with this condition.

Keywords

diabetic ketoacidosis - acromegaly - hyperosmolar hyperglycemic state - pituitary adenomas

Patient Consent Statement

Verbal informed consent was obtained from the patient for publication of this case report.

Authors' Contributions

All authors were involved in data collection, manuscript drafting, and finalizing. S.H. and H.A. collected the data. S.H. and R.A. were involved in intellectual input and performed manuscript writing, editing, and review. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Compliance with Ethical Principles

No ethical approval is required for single case report.

Availability of Data and Material

For confidentiality reasons, the original data cannot be shared.

Publikationsverlauf

Artikel online veröffentlicht:
11. März 2025

• References

• 1 Ershadinia N, Tritos NA. Diagnosis and treatment of acromegaly: an update. Mayo Clin Proc 2022; 97 (02) 333-346
• 2 Lim CT, Khoo B. Normal physiology of ACTH and GH release in the hypothalamus and anterior pituitary in man. In: Feingold KR, Anawalt B, Blackman MR. et al., eds. Endotext [Internet]. South Dartmouth, MA: MDText.com, Inc.,; 2000
• 3 Melmed S. Pathogenesis and diagnosis of growth hormone deficiency in adults. New Engl J Med 2019; 380 (26) 2551-2562
• 4 Hage M, Viengchareun S, Brunet E. et al. Genomic alterations and complex subclonal architecture in sporadic GH-secreting pituitary adenomas. J Clin Endocrinol Metab 2018; 103 (05) 1929-1939
• 5 Bogusławska A, Korbonits M. Genetics of acromegaly and gigantism. J Clin Med 2021; 10 (07) 1377
• 6 Rolla M, Jawiarczyk-Przybyłowska A, Halupczok-Żyła J. et al. Complications and comorbidities of acromegaly-retrospective study in Polish center. Front Endocrinol (Lausanne) 2021; 12: 642131
• 7 El-Kebbi IM, Bidikian NH, Hneiny L, Nasrallah MP. Epidemiology of type 2 diabetes in the Middle East and North Africa: challenges and call for action. World J Diabetes 2021; 12 (09) 1401-1425
• 8 Esposito D, Boguszewski CL, Colao A. et al. Diabetes mellitus in patients with acromegaly: pathophysiology, clinical challenges and management. Nat Rev Endocrinol 2024; 20 (09) 541-552
• 9 Moustaki M, Paschou SA, Xekouki P. et al. Secondary diabetes mellitus in acromegaly. Endocrine 2023; 81 (01) 1-15
• 10 Nielsen S, Møller N, Christiansen JS, Jørgensen JOL. Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure. Diabetes 2001; 50 (10) 2301-2308
• 11 Hjelholt AJ, Charidemou E, Griffin JL. et al. Insulin resistance induced by growth hormone is linked to lipolysis and associated with suppressed pyruvate dehydrogenase activity in skeletal muscle: a 2 × 2 factorial, randomised, crossover study in human individuals. Diabetologia 2020; 63 (12) 2641-2653
• 12 Arlien-Søborg MC, Dal J, Madsen MA. et al. Reversible insulin resistance in muscle and fat unrelated to the metabolic syndrome in patients with acromegaly. EBioMedicine 2022; 75: 103763